Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07456072

Effectiveness of Chlorhexidine Impregnated Gauze Versus Povidone Iodine Dressing in Post Trauma Wound Care

To compare rate of infection and wound healing between chlorhexidine impregnated paraffin gauze and dry povidone-iodine dressings in post-traumatic wounds.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients 18-65 years of age with acute post-trauma wounds.
  • Wounds that are clean contaminated at presentation.

Exclusion criteria

  • Patients with the known allergies to Chlorhexidine or Povidone-Iodine.
  • Chronic wounds or those with underlying chronic conditions, such as diabetes.
  • Patients with compromised immune systems.
  • Pregnant females

Treatment and study plan

Chlorhexidine impregnated paraffin gauze

Procedure

Paraffin gauze impregnated with 0.2 % chlorhexidine

Povidone iodine dressing

Procedure

Standard povidone iodine dressing

Primary outcomes

  1. Change in infection rate

    Time frame: 3 months

Secondary outcomes

  1. Change in Wound healing

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Pakistan Institute of Medical Sciences

Other Gov

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Mar 6, 2026
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.